| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Carcinogenesis |
American Health Foundation, Valhalla, New York 10595 [O. S. S., E. S. F., S. P. R., J. H. W.], and National Cancer Institute, NIH, Bethesda, Maryland 20892 [F. J. G.]
Methylazoxymethanol (MAM) and its chemical and metabolic precursor, azoxymethane (AOM), both strong colon carcinogens in rodents, can be metabolically activated by CYP2E1 in vitro. Using CYP2E1-null mice, we found that CYP2E1 deficiency differentially affects the activation of AOM and MAM, as reflected in DNA guanine alkylation in the colon and in the formation of colonic aberrant crypt foci (ACF). Male and female inbred 129/SV wild-type (WT) and CYP2E1-null (null) mice were treated with 189 µmol/kg of either AOM or methylazoxymethyl acetate (MAMAc), and 7-methylguanine (7-MeG) and O6-methylguanine (O6-MeG) were measured in the DNAs of various organs. The levels of O6-MeG (as pmol/nmol guanine) in the liver, colon, kidney, and lung of male null mice treated with AOM were 87, 48, 70, and 43% lower, respectively, than in AOM-treated WT mice. In null mice treated with MAMAc, the DNA O6-MeG levels were lower by 38% in the liver but were higher by 368, 146, and 194% in the colon, kidney, and lung, respectively, compared with the same organs of WT mice treated in the same way. Determination of ACF revealed that although AOM-induced ACF formation was significantly lower in the null group than in the WT group, MAMAc-induced ACF formation was significantly higher in the null group than in the WT group. These results demonstrate an important role for CYP2E1 in the in vivo activation of AOM and MAM and suggest that agents that modify CYP2E1 activity at the tumor initiation stage might either enhance or inhibit colon carcinogenesis, depending on whether AOM or MAMAc is used as the carcinogen. The mechanism of this effect is discussed.
This article has been cited by other articles:
|
|
 |
|
  D. W. Rosenberg, C. Giardina, and T. Tanaka Mouse models for the study of colon carcinogenesis Carcinogenesis, February 1, 2009; 30(2): 183 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Halberg, M. C. Larsen, T. L. Elmergreen, A. Y. Ko, A. A. Irving, L. Clipson, and C. R. Jefcoate Cyp1b1 Exerts Opposing Effects on Intestinal Tumorigenesis via Exogenous and Endogenous Substrates Cancer Res., September 15, 2008; 68(18): 7394 - 7402. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Gonzalez CYP2E1 Drug Metab. Dispos., January 1, 2007; 35(1): 1 - 8. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Fournier, J. Hawari, S. H. Streger, K. McClay, and P. B. Hatzinger Biotransformation of N-Nitrosodimethylamine by Pseudomonas mendocina KR1 Appl. Envir. Microbiol., October 1, 2006; 72(10): 6693 - 6698. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Y.A. Plate and D. D. Gallaher Effects of Indole-3-Carbinol and phenethyl isothiocyanate on colon carcinogenesis induced by azoxymethane in rats Carcinogenesis, February 1, 2006; 27(2): 287 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Suzuki, H. Kohno, S. Sugie, H. Nakagama, and T. Tanaka Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice Carcinogenesis, January 1, 2006; 27(1): 162 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Goodin and R. J. Rosengren Epigallocatechin Gallate Modulates CYP450 Isoforms in the Female Swiss-Webster Mouse Toxicol. Sci., December 1, 2003; 76(2): 262 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Kassie, S. Rabot, M. Uhl, W. Huber, H. M. Qin, C. Helma, R. Schulte-Hermann, and S. Knasmuller Chemoprotective effects of garden cress (Lepidium sativum) and its constituents towards 2-amino-3-methyl-imidazo[4,5-f]quinoline (IQ)-induced genotoxic effects and colonic preneoplastic lesions Carcinogenesis, July 1, 2002; 23(7): 1155 - 1161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Takagi, Y. Nakano, S. Takekoshi, T. Inagami, and M. Tamura Hemizygous mice for the angiotensin II type 2 receptor gene have attenuated susceptibility to azoxymethane-induced colon tumorigenesis Carcinogenesis, July 1, 2002; 23(7): 1235 - 1241. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
